Status:
RECRUITING
Precision Medicine for L/GCMN and Melanoma 2
Lead Sponsor:
Fundacion Clinic per a la Recerca Biomédica
Collaborating Sponsors:
Hospital Clinic of Barcelona
Conditions:
Melanoma (Skin Cancer)
Nevi and Melanomas
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective is to evaluate the possibility of using minimally and non-invasive technologies (skin patch and breath analyzer) based on the detection of volatile organic compounds (VOCs) for t...
Detailed Description
This is a unicentric national prospective observational study aimed at evaluating the use of two devices (skin patch and breath analyzer) for the non or minimally invasive diagnosis of metastatic mela...
Eligibility Criteria
Inclusion
- Be over 18 years old
- Have a histopathological confirmed melanoma diagnosis (stage II, III or IV AJCC)
Exclusion
- Not signing the informed consent form
- Present other cancers or chronic diseases (such as diabetes, asthma, etc.), which may affect the volatile organic compound profiles
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06605443
Start Date
January 1 2025
End Date
December 1 2026
Last Update
February 27 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínic de Barcelona (Dermatology service)
Barcelona, Spain, 08036
2
Hospital Clínic Barcelona
Barcelona, Spain
3
Hospital Clínic Barcelona
Barcelona, Spain